nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—ALB—multiple sclerosis	0.282	1	CbGaD
Furosemide—PGD—Methotrexate—multiple sclerosis	0.201	0.442	CbGbCtD
Furosemide—SLC22A11—Methotrexate—multiple sclerosis	0.0597	0.131	CbGbCtD
Furosemide—ABCC2—Dexamethasone—multiple sclerosis	0.0411	0.0902	CbGbCtD
Furosemide—ALB—Prednisone—multiple sclerosis	0.0411	0.0901	CbGbCtD
Furosemide—SLC22A8—Methotrexate—multiple sclerosis	0.0347	0.0762	CbGbCtD
Furosemide—ABCC2—Methotrexate—multiple sclerosis	0.033	0.0725	CbGbCtD
Furosemide—SLC22A6—Methotrexate—multiple sclerosis	0.0242	0.0531	CbGbCtD
Furosemide—ALB—Methotrexate—multiple sclerosis	0.0206	0.0452	CbGbCtD
Furosemide—CA1—nerve—multiple sclerosis	0.00303	0.057	CbGeAlD
Furosemide—CA4—nerve—multiple sclerosis	0.00237	0.0445	CbGeAlD
Furosemide—CA7—midbrain—multiple sclerosis	0.00161	0.0303	CbGeAlD
Furosemide—PGD—retina—multiple sclerosis	0.0015	0.0282	CbGeAlD
Furosemide—CA14—medulla oblongata—multiple sclerosis	0.00147	0.0276	CbGeAlD
Furosemide—CA14—midbrain—multiple sclerosis	0.00134	0.0252	CbGeAlD
Furosemide—CA14—spinal cord—multiple sclerosis	0.00131	0.0246	CbGeAlD
Furosemide—CA7—cerebellum—multiple sclerosis	0.00125	0.0234	CbGeAlD
Furosemide—SLC12A1—spinal cord—multiple sclerosis	0.00118	0.0221	CbGeAlD
Furosemide—CA9—cerebellum—multiple sclerosis	0.00109	0.0206	CbGeAlD
Furosemide—PGD—medulla oblongata—multiple sclerosis	0.00108	0.0204	CbGeAlD
Furosemide—CA14—cerebellum—multiple sclerosis	0.00104	0.0195	CbGeAlD
Furosemide—CA4—brainstem—multiple sclerosis	0.00102	0.0191	CbGeAlD
Furosemide—CA7—brain—multiple sclerosis	0.00101	0.019	CbGeAlD
Furosemide—PGD—midbrain—multiple sclerosis	0.000991	0.0186	CbGeAlD
Furosemide—SLC12A1—nervous system—multiple sclerosis	0.000991	0.0186	CbGeAlD
Furosemide—PGD—spinal cord—multiple sclerosis	0.000967	0.0182	CbGeAlD
Furosemide—SLC12A1—central nervous system—multiple sclerosis	0.000954	0.0179	CbGeAlD
Furosemide—SLCO2A1—nervous system—multiple sclerosis	0.000914	0.0172	CbGeAlD
Furosemide—SLCO2A1—central nervous system—multiple sclerosis	0.00088	0.0165	CbGeAlD
Furosemide—CA12—nervous system—multiple sclerosis	0.000861	0.0162	CbGeAlD
Furosemide—CA14—brain—multiple sclerosis	0.000844	0.0159	CbGeAlD
Furosemide—CA2—brainstem—multiple sclerosis	0.000843	0.0158	CbGeAlD
Furosemide—CA12—central nervous system—multiple sclerosis	0.000829	0.0156	CbGeAlD
Furosemide—PGD—nervous system—multiple sclerosis	0.000815	0.0153	CbGeAlD
Furosemide—CA2—retina—multiple sclerosis	0.000814	0.0153	CbGeAlD
Furosemide—CA1—spinal cord—multiple sclerosis	0.000809	0.0152	CbGeAlD
Furosemide—SLC22A5—retina—multiple sclerosis	0.000801	0.015	CbGeAlD
Furosemide—PGD—central nervous system—multiple sclerosis	0.000785	0.0147	CbGeAlD
Furosemide—CA5B—nervous system—multiple sclerosis	0.000772	0.0145	CbGeAlD
Furosemide—PGD—cerebellum—multiple sclerosis	0.000767	0.0144	CbGeAlD
Furosemide—SLC12A1—brain—multiple sclerosis	0.000757	0.0142	CbGeAlD
Furosemide—CA5B—central nervous system—multiple sclerosis	0.000743	0.014	CbGeAlD
Furosemide—SLC22A6—brain—multiple sclerosis	0.000734	0.0138	CbGeAlD
Furosemide—CA4—medulla oblongata—multiple sclerosis	0.000709	0.0133	CbGeAlD
Furosemide—SLCO2A1—brain—multiple sclerosis	0.000699	0.0131	CbGeAlD
Furosemide—CA1—nervous system—multiple sclerosis	0.000682	0.0128	CbGeAlD
Furosemide—CA12—brain—multiple sclerosis	0.000658	0.0124	CbGeAlD
Furosemide—CA1—central nervous system—multiple sclerosis	0.000656	0.0123	CbGeAlD
Furosemide—CA4—midbrain—multiple sclerosis	0.000648	0.0122	CbGeAlD
Furosemide—CA4—spinal cord—multiple sclerosis	0.000632	0.0119	CbGeAlD
Furosemide—PGD—brain—multiple sclerosis	0.000623	0.0117	CbGeAlD
Furosemide—CA5B—brain—multiple sclerosis	0.00059	0.0111	CbGeAlD
Furosemide—CA2—medulla oblongata—multiple sclerosis	0.000588	0.0111	CbGeAlD
Furosemide—SLC22A5—medulla oblongata—multiple sclerosis	0.000579	0.0109	CbGeAlD
Furosemide—SLC22A8—nervous system—multiple sclerosis	0.000575	0.0108	CbGeAlD
Furosemide—SLC22A8—central nervous system—multiple sclerosis	0.000554	0.0104	CbGeAlD
Furosemide—CA2—midbrain—multiple sclerosis	0.000538	0.0101	CbGeAlD
Furosemide—CA4—nervous system—multiple sclerosis	0.000533	0.01	CbGeAlD
Furosemide—SLC22A5—midbrain—multiple sclerosis	0.000529	0.00994	CbGeAlD
Furosemide—CA2—spinal cord—multiple sclerosis	0.000524	0.00985	CbGeAlD
Furosemide—CA1—brain—multiple sclerosis	0.000521	0.00979	CbGeAlD
Furosemide—SLC22A5—spinal cord—multiple sclerosis	0.000516	0.00969	CbGeAlD
Furosemide—CA4—central nervous system—multiple sclerosis	0.000513	0.00964	CbGeAlD
Furosemide—CA4—cerebellum—multiple sclerosis	0.000501	0.00942	CbGeAlD
Furosemide—ALB—brain—multiple sclerosis	0.000458	0.0086	CbGeAlD
Furosemide—CA2—nervous system—multiple sclerosis	0.000442	0.0083	CbGeAlD
Furosemide—SLC22A8—brain—multiple sclerosis	0.00044	0.00826	CbGeAlD
Furosemide—CA2—central nervous system—multiple sclerosis	0.000425	0.00799	CbGeAlD
Furosemide—CA2—cerebellum—multiple sclerosis	0.000416	0.00781	CbGeAlD
Furosemide—SLC22A5—cerebellum—multiple sclerosis	0.000409	0.00769	CbGeAlD
Furosemide—CA4—brain—multiple sclerosis	0.000407	0.00765	CbGeAlD
Furosemide—CA2—brain—multiple sclerosis	0.000338	0.00635	CbGeAlD
Furosemide—SLC22A5—brain—multiple sclerosis	0.000332	0.00624	CbGeAlD
Furosemide—Vision blurred—Prednisolone—multiple sclerosis	0.000283	0.00142	CcSEcCtD
Furosemide—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000283	0.00142	CcSEcCtD
Furosemide—Hyperglycaemia—Prednisone—multiple sclerosis	0.000283	0.00142	CcSEcCtD
Furosemide—Hypotension—Mitoxantrone—multiple sclerosis	0.000279	0.0014	CcSEcCtD
Furosemide—Visual impairment—Dexamethasone—multiple sclerosis	0.000278	0.00139	CcSEcCtD
Furosemide—Visual impairment—Betamethasone—multiple sclerosis	0.000278	0.00139	CcSEcCtD
Furosemide—Erythema—Triamcinolone—multiple sclerosis	0.000276	0.00138	CcSEcCtD
Furosemide—Malnutrition—Methylprednisolone—multiple sclerosis	0.000276	0.00138	CcSEcCtD
Furosemide—Erythema—Methylprednisolone—multiple sclerosis	0.000276	0.00138	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.000273	0.00137	CcSEcCtD
Furosemide—Hypersensitivity—Azathioprine—multiple sclerosis	0.000272	0.00136	CcSEcCtD
Furosemide—Dysgeusia—Triamcinolone—multiple sclerosis	0.000271	0.00135	CcSEcCtD
Furosemide—Nausea—Cladribine—multiple sclerosis	0.00027	0.00135	CcSEcCtD
Furosemide—Vertigo—Prednisolone—multiple sclerosis	0.00027	0.00135	CcSEcCtD
Furosemide—Eye disorder—Betamethasone—multiple sclerosis	0.000269	0.00135	CcSEcCtD
Furosemide—Eye disorder—Dexamethasone—multiple sclerosis	0.000269	0.00135	CcSEcCtD
Furosemide—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000268	0.00134	CcSEcCtD
Furosemide—Somnolence—Mitoxantrone—multiple sclerosis	0.000266	0.00133	CcSEcCtD
Furosemide—Angiopathy—Dexamethasone—multiple sclerosis	0.000261	0.00131	CcSEcCtD
Furosemide—Angiopathy—Betamethasone—multiple sclerosis	0.000261	0.00131	CcSEcCtD
Furosemide—Decreased appetite—Mitoxantrone—multiple sclerosis	0.00026	0.0013	CcSEcCtD
Furosemide—Eosinophilia—Methotrexate—multiple sclerosis	0.000259	0.0013	CcSEcCtD
Furosemide—Fatigue—Mitoxantrone—multiple sclerosis	0.000258	0.00129	CcSEcCtD
Furosemide—Arrhythmia—Betamethasone—multiple sclerosis	0.000257	0.00129	CcSEcCtD
Furosemide—Arrhythmia—Dexamethasone—multiple sclerosis	0.000257	0.00129	CcSEcCtD
Furosemide—Pancreatitis—Methotrexate—multiple sclerosis	0.000257	0.00129	CcSEcCtD
Furosemide—Constipation—Mitoxantrone—multiple sclerosis	0.000256	0.00128	CcSEcCtD
Furosemide—Pain—Mitoxantrone—multiple sclerosis	0.000256	0.00128	CcSEcCtD
Furosemide—Diarrhoea—Azathioprine—multiple sclerosis	0.000253	0.00127	CcSEcCtD
Furosemide—Erythema—Dexamethasone—multiple sclerosis	0.000251	0.00126	CcSEcCtD
Furosemide—Erythema—Betamethasone—multiple sclerosis	0.000251	0.00126	CcSEcCtD
Furosemide—Vertigo—Triamcinolone—multiple sclerosis	0.000248	0.00124	CcSEcCtD
Furosemide—Vertigo—Methylprednisolone—multiple sclerosis	0.000248	0.00124	CcSEcCtD
Furosemide—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000246	0.00123	CcSEcCtD
Furosemide—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000245	0.00123	CcSEcCtD
Furosemide—Dizziness—Azathioprine—multiple sclerosis	0.000245	0.00122	CcSEcCtD
Furosemide—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000244	0.00122	CcSEcCtD
Furosemide—Shock—Prednisolone—multiple sclerosis	0.000241	0.00121	CcSEcCtD
Furosemide—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000239	0.0012	CcSEcCtD
Furosemide—Urticaria—Mitoxantrone—multiple sclerosis	0.000238	0.00119	CcSEcCtD
Furosemide—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000237	0.00119	CcSEcCtD
Furosemide—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000236	0.00118	CcSEcCtD
Furosemide—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000236	0.00118	CcSEcCtD
Furosemide—Vomiting—Azathioprine—multiple sclerosis	0.000235	0.00118	CcSEcCtD
Furosemide—Eye disorder—Prednisone—multiple sclerosis	0.000234	0.00117	CcSEcCtD
Furosemide—Drowsiness—Methotrexate—multiple sclerosis	0.000234	0.00117	CcSEcCtD
Furosemide—Rash—Azathioprine—multiple sclerosis	0.000233	0.00117	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000233	0.00117	CcSEcCtD
Furosemide—Dermatitis—Azathioprine—multiple sclerosis	0.000233	0.00117	CcSEcCtD
Furosemide—Headache—Azathioprine—multiple sclerosis	0.000232	0.00116	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000232	0.00116	CcSEcCtD
Furosemide—Dry mouth—Triamcinolone—multiple sclerosis	0.00023	0.00115	CcSEcCtD
Furosemide—Renal failure—Methotrexate—multiple sclerosis	0.00023	0.00115	CcSEcCtD
Furosemide—Angiopathy—Prednisone—multiple sclerosis	0.000228	0.00114	CcSEcCtD
Furosemide—Confusional state—Methylprednisolone—multiple sclerosis	0.000227	0.00114	CcSEcCtD
Furosemide—Immune system disorder—Prednisone—multiple sclerosis	0.000227	0.00113	CcSEcCtD
Furosemide—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000226	0.00113	CcSEcCtD
Furosemide—Vertigo—Betamethasone—multiple sclerosis	0.000225	0.00113	CcSEcCtD
Furosemide—Vertigo—Dexamethasone—multiple sclerosis	0.000225	0.00113	CcSEcCtD
Furosemide—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000225	0.00113	CcSEcCtD
Furosemide—Arrhythmia—Prednisone—multiple sclerosis	0.000224	0.00112	CcSEcCtD
Furosemide—Sweating—Methotrexate—multiple sclerosis	0.000224	0.00112	CcSEcCtD
Furosemide—Shock—Triamcinolone—multiple sclerosis	0.000222	0.00111	CcSEcCtD
Furosemide—Shock—Methylprednisolone—multiple sclerosis	0.000221	0.00111	CcSEcCtD
Furosemide—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000221	0.00111	CcSEcCtD
Furosemide—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000221	0.0011	CcSEcCtD
Furosemide—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00022	0.0011	CcSEcCtD
Furosemide—Paraesthesia—Prednisolone—multiple sclerosis	0.00022	0.0011	CcSEcCtD
Furosemide—Nausea—Azathioprine—multiple sclerosis	0.00022	0.0011	CcSEcCtD
Furosemide—Skin disorder—Methylprednisolone—multiple sclerosis	0.000219	0.00109	CcSEcCtD
Furosemide—Erythema—Prednisone—multiple sclerosis	0.000218	0.00109	CcSEcCtD
Furosemide—Malnutrition—Prednisone—multiple sclerosis	0.000218	0.00109	CcSEcCtD
Furosemide—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000218	0.00109	CcSEcCtD
Furosemide—Agranulocytosis—Methotrexate—multiple sclerosis	0.000218	0.00109	CcSEcCtD
Furosemide—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000218	0.00109	CcSEcCtD
Furosemide—Asthenia—Mitoxantrone—multiple sclerosis	0.000215	0.00107	CcSEcCtD
Furosemide—Hypotension—Methylprednisolone—multiple sclerosis	0.00021	0.00105	CcSEcCtD
Furosemide—Pain—Prednisolone—multiple sclerosis	0.00021	0.00105	CcSEcCtD
Furosemide—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000207	0.00104	CcSEcCtD
Furosemide—Vision blurred—Prednisone—multiple sclerosis	0.000206	0.00103	CcSEcCtD
Furosemide—Urethral disorder—Methotrexate—multiple sclerosis	0.000206	0.00103	CcSEcCtD
Furosemide—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000205	0.00102	CcSEcCtD
Furosemide—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000205	0.00102	CcSEcCtD
Furosemide—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000205	0.00102	CcSEcCtD
Furosemide—Paraesthesia—Triamcinolone—multiple sclerosis	0.000203	0.00101	CcSEcCtD
Furosemide—Feeling abnormal—Prednisolone—multiple sclerosis	0.000202	0.00101	CcSEcCtD
Furosemide—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000202	0.00101	CcSEcCtD
Furosemide—Visual impairment—Methotrexate—multiple sclerosis	0.000202	0.00101	CcSEcCtD
Furosemide—Anaemia—Prednisone—multiple sclerosis	0.000202	0.00101	CcSEcCtD
Furosemide—Shock—Dexamethasone—multiple sclerosis	0.000201	0.00101	CcSEcCtD
Furosemide—Shock—Betamethasone—multiple sclerosis	0.000201	0.00101	CcSEcCtD
Furosemide—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000201	0.001	CcSEcCtD
Furosemide—Nervous system disorder—Betamethasone—multiple sclerosis	0.000201	0.001	CcSEcCtD
Furosemide—Agitation—Prednisone—multiple sclerosis	0.000201	0.001	CcSEcCtD
Furosemide—Thrombocytopenia—Betamethasone—multiple sclerosis	0.0002	0.001	CcSEcCtD
Furosemide—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.0002	0.001	CcSEcCtD
Furosemide—Erythema multiforme—Methotrexate—multiple sclerosis	0.000198	0.000992	CcSEcCtD
Furosemide—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000198	0.000991	CcSEcCtD
Furosemide—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000198	0.000991	CcSEcCtD
Furosemide—Vertigo—Prednisone—multiple sclerosis	0.000196	0.000982	CcSEcCtD
Furosemide—Eye disorder—Methotrexate—multiple sclerosis	0.000196	0.000981	CcSEcCtD
Furosemide—Tinnitus—Methotrexate—multiple sclerosis	0.000195	0.000979	CcSEcCtD
Furosemide—Anorexia—Dexamethasone—multiple sclerosis	0.000195	0.000977	CcSEcCtD
Furosemide—Anorexia—Betamethasone—multiple sclerosis	0.000195	0.000977	CcSEcCtD
Furosemide—Urticaria—Prednisolone—multiple sclerosis	0.000195	0.000976	CcSEcCtD
Furosemide—Fatigue—Triamcinolone—multiple sclerosis	0.000194	0.000974	CcSEcCtD
Furosemide—Fatigue—Methylprednisolone—multiple sclerosis	0.000194	0.000971	CcSEcCtD
Furosemide—Pain—Triamcinolone—multiple sclerosis	0.000193	0.000966	CcSEcCtD
Furosemide—Hypotension—Dexamethasone—multiple sclerosis	0.000191	0.000957	CcSEcCtD
Furosemide—Hypotension—Betamethasone—multiple sclerosis	0.000191	0.000957	CcSEcCtD
Furosemide—Angiopathy—Methotrexate—multiple sclerosis	0.00019	0.000952	CcSEcCtD
Furosemide—Vomiting—Mitoxantrone—multiple sclerosis	0.00019	0.000952	CcSEcCtD
Furosemide—Immune system disorder—Methotrexate—multiple sclerosis	0.000189	0.000948	CcSEcCtD
Furosemide—Rash—Mitoxantrone—multiple sclerosis	0.000189	0.000944	CcSEcCtD
Furosemide—Dermatitis—Mitoxantrone—multiple sclerosis	0.000188	0.000943	CcSEcCtD
Furosemide—Headache—Mitoxantrone—multiple sclerosis	0.000187	0.000938	CcSEcCtD
Furosemide—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000186	0.000931	CcSEcCtD
Furosemide—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000185	0.000928	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000185	0.000924	CcSEcCtD
Furosemide—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000184	0.000921	CcSEcCtD
Furosemide—Paraesthesia—Betamethasone—multiple sclerosis	0.000184	0.00092	CcSEcCtD
Furosemide—Paraesthesia—Dexamethasone—multiple sclerosis	0.000184	0.00092	CcSEcCtD
Furosemide—Erythema—Methotrexate—multiple sclerosis	0.000183	0.000914	CcSEcCtD
Furosemide—Malnutrition—Methotrexate—multiple sclerosis	0.000183	0.000914	CcSEcCtD
Furosemide—Hypersensitivity—Prednisolone—multiple sclerosis	0.000181	0.000905	CcSEcCtD
Furosemide—Urticaria—Triamcinolone—multiple sclerosis	0.000179	0.000897	CcSEcCtD
Furosemide—Urticaria—Methylprednisolone—multiple sclerosis	0.000179	0.000895	CcSEcCtD
Furosemide—Dysgeusia—Methotrexate—multiple sclerosis	0.000179	0.000895	CcSEcCtD
Furosemide—Body temperature increased—Triamcinolone—multiple sclerosis	0.000178	0.000893	CcSEcCtD
Furosemide—Anaphylactic shock—Prednisone—multiple sclerosis	0.000178	0.000892	CcSEcCtD
Furosemide—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000178	0.000891	CcSEcCtD
Furosemide—Decreased appetite—Dexamethasone—multiple sclerosis	0.000178	0.000891	CcSEcCtD
Furosemide—Decreased appetite—Betamethasone—multiple sclerosis	0.000178	0.000891	CcSEcCtD
Furosemide—Nausea—Mitoxantrone—multiple sclerosis	0.000178	0.000889	CcSEcCtD
Furosemide—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000177	0.000885	CcSEcCtD
Furosemide—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000177	0.000885	CcSEcCtD
Furosemide—Fatigue—Betamethasone—multiple sclerosis	0.000176	0.000883	CcSEcCtD
Furosemide—Fatigue—Dexamethasone—multiple sclerosis	0.000176	0.000883	CcSEcCtD
Furosemide—Shock—Prednisone—multiple sclerosis	0.000175	0.000878	CcSEcCtD
Furosemide—Pain—Betamethasone—multiple sclerosis	0.000175	0.000876	CcSEcCtD
Furosemide—Pain—Dexamethasone—multiple sclerosis	0.000175	0.000876	CcSEcCtD
Furosemide—Nervous system disorder—Prednisone—multiple sclerosis	0.000175	0.000875	CcSEcCtD
Furosemide—Skin disorder—Prednisone—multiple sclerosis	0.000173	0.000867	CcSEcCtD
Furosemide—Hyperhidrosis—Prednisone—multiple sclerosis	0.000172	0.000863	CcSEcCtD
Furosemide—Vision blurred—Methotrexate—multiple sclerosis	0.000172	0.000861	CcSEcCtD
Furosemide—Anorexia—Prednisone—multiple sclerosis	0.00017	0.000851	CcSEcCtD
Furosemide—Anaemia—Methotrexate—multiple sclerosis	0.000169	0.000845	CcSEcCtD
Furosemide—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000169	0.000844	CcSEcCtD
Furosemide—Feeling abnormal—Betamethasone—multiple sclerosis	0.000169	0.000844	CcSEcCtD
Furosemide—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000167	0.000838	CcSEcCtD
Furosemide—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000167	0.000838	CcSEcCtD
Furosemide—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000166	0.000832	CcSEcCtD
Furosemide—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000166	0.00083	CcSEcCtD
Furosemide—Vertigo—Methotrexate—multiple sclerosis	0.000164	0.000821	CcSEcCtD
Furosemide—Leukopenia—Methotrexate—multiple sclerosis	0.000163	0.000818	CcSEcCtD
Furosemide—Urticaria—Dexamethasone—multiple sclerosis	0.000163	0.000814	CcSEcCtD
Furosemide—Urticaria—Betamethasone—multiple sclerosis	0.000163	0.000814	CcSEcCtD
Furosemide—Dizziness—Prednisolone—multiple sclerosis	0.000162	0.000812	CcSEcCtD
Furosemide—Asthenia—Triamcinolone—multiple sclerosis	0.000162	0.00081	CcSEcCtD
Furosemide—Abdominal pain—Dexamethasone—multiple sclerosis	0.000162	0.00081	CcSEcCtD
Furosemide—Abdominal pain—Betamethasone—multiple sclerosis	0.000162	0.00081	CcSEcCtD
Furosemide—Body temperature increased—Dexamethasone—multiple sclerosis	0.000162	0.00081	CcSEcCtD
Furosemide—Body temperature increased—Betamethasone—multiple sclerosis	0.000162	0.00081	CcSEcCtD
Furosemide—Asthenia—Methylprednisolone—multiple sclerosis	0.000161	0.000808	CcSEcCtD
Furosemide—Paraesthesia—Prednisone—multiple sclerosis	0.00016	0.000801	CcSEcCtD
Furosemide—Pruritus—Triamcinolone—multiple sclerosis	0.00016	0.000799	CcSEcCtD
Furosemide—Pruritus—Methylprednisolone—multiple sclerosis	0.000159	0.000797	CcSEcCtD
Furosemide—Decreased appetite—Prednisone—multiple sclerosis	0.000155	0.000776	CcSEcCtD
Furosemide—Rash—Prednisolone—multiple sclerosis	0.000155	0.000774	CcSEcCtD
Furosemide—Dermatitis—Prednisolone—multiple sclerosis	0.000155	0.000774	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000154	0.000773	CcSEcCtD
Furosemide—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000154	0.000771	CcSEcCtD
Furosemide—Fatigue—Prednisone—multiple sclerosis	0.000154	0.000769	CcSEcCtD
Furosemide—Headache—Prednisolone—multiple sclerosis	0.000154	0.000769	CcSEcCtD
Furosemide—Constipation—Prednisone—multiple sclerosis	0.000152	0.000763	CcSEcCtD
Furosemide—Confusional state—Methotrexate—multiple sclerosis	0.00015	0.000752	CcSEcCtD
Furosemide—Dizziness—Triamcinolone—multiple sclerosis	0.000149	0.000747	CcSEcCtD
Furosemide—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000149	0.000746	CcSEcCtD
Furosemide—Dizziness—Methylprednisolone—multiple sclerosis	0.000149	0.000745	CcSEcCtD
Furosemide—Feeling abnormal—Prednisone—multiple sclerosis	0.000147	0.000735	CcSEcCtD
Furosemide—Asthenia—Betamethasone—multiple sclerosis	0.000147	0.000735	CcSEcCtD
Furosemide—Asthenia—Dexamethasone—multiple sclerosis	0.000147	0.000735	CcSEcCtD
Furosemide—Nervous system disorder—Methotrexate—multiple sclerosis	0.000146	0.000731	CcSEcCtD
Furosemide—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000146	0.00073	CcSEcCtD
Furosemide—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000146	0.00073	CcSEcCtD
Furosemide—Nausea—Prednisolone—multiple sclerosis	0.000146	0.000729	CcSEcCtD
Furosemide—Pruritus—Betamethasone—multiple sclerosis	0.000145	0.000725	CcSEcCtD
Furosemide—Pruritus—Dexamethasone—multiple sclerosis	0.000145	0.000725	CcSEcCtD
Furosemide—Skin disorder—Methotrexate—multiple sclerosis	0.000145	0.000724	CcSEcCtD
Furosemide—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000144	0.000721	CcSEcCtD
Furosemide—Vomiting—Triamcinolone—multiple sclerosis	0.000143	0.000718	CcSEcCtD
Furosemide—Vomiting—Methylprednisolone—multiple sclerosis	0.000143	0.000716	CcSEcCtD
Furosemide—Rash—Triamcinolone—multiple sclerosis	0.000142	0.000712	CcSEcCtD
Furosemide—Dermatitis—Triamcinolone—multiple sclerosis	0.000142	0.000711	CcSEcCtD
Furosemide—Anorexia—Methotrexate—multiple sclerosis	0.000142	0.000711	CcSEcCtD
Furosemide—Rash—Methylprednisolone—multiple sclerosis	0.000142	0.00071	CcSEcCtD
Furosemide—Dermatitis—Methylprednisolone—multiple sclerosis	0.000142	0.00071	CcSEcCtD
Furosemide—Urticaria—Prednisone—multiple sclerosis	0.000142	0.000709	CcSEcCtD
Furosemide—Headache—Triamcinolone—multiple sclerosis	0.000141	0.000707	CcSEcCtD
Furosemide—Headache—Methylprednisolone—multiple sclerosis	0.000141	0.000706	CcSEcCtD
Furosemide—Abdominal pain—Prednisone—multiple sclerosis	0.000141	0.000705	CcSEcCtD
Furosemide—Body temperature increased—Prednisone—multiple sclerosis	0.000141	0.000705	CcSEcCtD
Furosemide—Diarrhoea—Dexamethasone—multiple sclerosis	0.00014	0.000701	CcSEcCtD
Furosemide—Diarrhoea—Betamethasone—multiple sclerosis	0.00014	0.000701	CcSEcCtD
Furosemide—Hypotension—Methotrexate—multiple sclerosis	0.000139	0.000697	CcSEcCtD
Furosemide—Dizziness—Betamethasone—multiple sclerosis	0.000135	0.000678	CcSEcCtD
Furosemide—Dizziness—Dexamethasone—multiple sclerosis	0.000135	0.000678	CcSEcCtD
Furosemide—Nausea—Triamcinolone—multiple sclerosis	0.000134	0.000671	CcSEcCtD
Furosemide—Paraesthesia—Methotrexate—multiple sclerosis	0.000134	0.00067	CcSEcCtD
Furosemide—Nausea—Methylprednisolone—multiple sclerosis	0.000134	0.000669	CcSEcCtD
Furosemide—Somnolence—Methotrexate—multiple sclerosis	0.000132	0.000663	CcSEcCtD
Furosemide—Hypersensitivity—Prednisone—multiple sclerosis	0.000131	0.000657	CcSEcCtD
Furosemide—Vomiting—Dexamethasone—multiple sclerosis	0.00013	0.000651	CcSEcCtD
Furosemide—Vomiting—Betamethasone—multiple sclerosis	0.00013	0.000651	CcSEcCtD
Furosemide—Decreased appetite—Methotrexate—multiple sclerosis	0.000129	0.000648	CcSEcCtD
Furosemide—Rash—Betamethasone—multiple sclerosis	0.000129	0.000646	CcSEcCtD
Furosemide—Rash—Dexamethasone—multiple sclerosis	0.000129	0.000646	CcSEcCtD
Furosemide—Dermatitis—Betamethasone—multiple sclerosis	0.000129	0.000645	CcSEcCtD
Furosemide—Dermatitis—Dexamethasone—multiple sclerosis	0.000129	0.000645	CcSEcCtD
Furosemide—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000129	0.000644	CcSEcCtD
Furosemide—Fatigue—Methotrexate—multiple sclerosis	0.000128	0.000643	CcSEcCtD
Furosemide—Headache—Dexamethasone—multiple sclerosis	0.000128	0.000642	CcSEcCtD
Furosemide—Headache—Betamethasone—multiple sclerosis	0.000128	0.000642	CcSEcCtD
Furosemide—Asthenia—Prednisone—multiple sclerosis	0.000128	0.00064	CcSEcCtD
Furosemide—Pain—Methotrexate—multiple sclerosis	0.000127	0.000638	CcSEcCtD
Furosemide—Pruritus—Prednisone—multiple sclerosis	0.000126	0.000631	CcSEcCtD
Furosemide—Feeling abnormal—Methotrexate—multiple sclerosis	0.000123	0.000615	CcSEcCtD
Furosemide—Diarrhoea—Prednisone—multiple sclerosis	0.000122	0.000611	CcSEcCtD
Furosemide—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000122	0.00061	CcSEcCtD
Furosemide—Nausea—Betamethasone—multiple sclerosis	0.000122	0.000609	CcSEcCtD
Furosemide—Nausea—Dexamethasone—multiple sclerosis	0.000122	0.000609	CcSEcCtD
Furosemide—Urticaria—Methotrexate—multiple sclerosis	0.000118	0.000592	CcSEcCtD
Furosemide—Dizziness—Prednisone—multiple sclerosis	0.000118	0.00059	CcSEcCtD
Furosemide—Abdominal pain—Methotrexate—multiple sclerosis	0.000118	0.00059	CcSEcCtD
Furosemide—Body temperature increased—Methotrexate—multiple sclerosis	0.000118	0.00059	CcSEcCtD
Furosemide—Vomiting—Prednisone—multiple sclerosis	0.000113	0.000567	CcSEcCtD
Furosemide—Rash—Prednisone—multiple sclerosis	0.000112	0.000563	CcSEcCtD
Furosemide—Dermatitis—Prednisone—multiple sclerosis	0.000112	0.000562	CcSEcCtD
Furosemide—Headache—Prednisone—multiple sclerosis	0.000112	0.000559	CcSEcCtD
Furosemide—Hypersensitivity—Methotrexate—multiple sclerosis	0.00011	0.000549	CcSEcCtD
Furosemide—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000108	0.0115	CbGpPWpGaD
Furosemide—Asthenia—Methotrexate—multiple sclerosis	0.000107	0.000535	CcSEcCtD
Furosemide—Nausea—Prednisone—multiple sclerosis	0.000106	0.00053	CcSEcCtD
Furosemide—Pruritus—Methotrexate—multiple sclerosis	0.000105	0.000528	CcSEcCtD
Furosemide—Diarrhoea—Methotrexate—multiple sclerosis	0.000102	0.00051	CcSEcCtD
Furosemide—SLCO2A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	9.88e-05	0.0105	CbGpPWpGaD
Furosemide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	9.86e-05	0.0105	CbGpPWpGaD
Furosemide—Dizziness—Methotrexate—multiple sclerosis	9.85e-05	0.000493	CcSEcCtD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	9.48e-05	0.0101	CbGpPWpGaD
Furosemide—Vomiting—Methotrexate—multiple sclerosis	9.47e-05	0.000474	CcSEcCtD
Furosemide—Rash—Methotrexate—multiple sclerosis	9.39e-05	0.00047	CcSEcCtD
Furosemide—Dermatitis—Methotrexate—multiple sclerosis	9.38e-05	0.00047	CcSEcCtD
Furosemide—Headache—Methotrexate—multiple sclerosis	9.33e-05	0.000467	CcSEcCtD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	9.29e-05	0.00989	CbGpPWpGaD
Furosemide—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	9.13e-05	0.00972	CbGpPWpGaD
Furosemide—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	8.87e-05	0.00944	CbGpPWpGaD
Furosemide—Nausea—Methotrexate—multiple sclerosis	8.85e-05	0.000443	CcSEcCtD
Furosemide—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	8.26e-05	0.00879	CbGpPWpGaD
Furosemide—SLC12A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	8.24e-05	0.00878	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.91e-05	0.00842	CbGpPWpGaD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	7.83e-05	0.00834	CbGpPWpGaD
Furosemide—ALB—HDL-mediated lipid transport—APOE—multiple sclerosis	7.33e-05	0.0078	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.18e-05	0.00765	CbGpPWpGaD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	7.08e-05	0.00754	CbGpPWpGaD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	7.04e-05	0.00749	CbGpPWpGaD
Furosemide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	6.89e-05	0.00734	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6e-05	0.00638	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—PLEK—multiple sclerosis	5.98e-05	0.00637	CbGpPWpGaD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	5.94e-05	0.00632	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	5.91e-05	0.00629	CbGpPWpGaD
Furosemide—CA14—Metabolism—SRM—multiple sclerosis	5.7e-05	0.00607	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—multiple sclerosis	5.7e-05	0.00607	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.68e-05	0.00605	CbGpPWpGaD
Furosemide—CA6—Metabolism—SRM—multiple sclerosis	5.55e-05	0.00591	CbGpPWpGaD
Furosemide—CA5A—Metabolism—SRM—multiple sclerosis	5.55e-05	0.00591	CbGpPWpGaD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	5.37e-05	0.00572	CbGpPWpGaD
Furosemide—PGD—Metabolism—SRM—multiple sclerosis	5.36e-05	0.0057	CbGpPWpGaD
Furosemide—CA7—Metabolism—SRM—multiple sclerosis	5.18e-05	0.00552	CbGpPWpGaD
Furosemide—CA5B—Metabolism—SRM—multiple sclerosis	5.18e-05	0.00552	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.02e-05	0.00534	CbGpPWpGaD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	4.92e-05	0.00524	CbGpPWpGaD
Furosemide—CA12—Metabolism—SRM—multiple sclerosis	4.8e-05	0.00511	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.74e-05	0.00505	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.72e-05	0.00503	CbGpPWpGaD
Furosemide—CA1—C-MYB transcription factor network—CD4—multiple sclerosis	4.65e-05	0.00495	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	4.48e-05	0.00477	CbGpPWpGaD
Furosemide—ALB—Lipoprotein metabolism—APOE—multiple sclerosis	4.21e-05	0.00448	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.19e-05	0.00446	CbGpPWpGaD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	4.15e-05	0.00442	CbGpPWpGaD
Furosemide—PGD—Disease—GPC5—multiple sclerosis	4.12e-05	0.00439	CbGpPWpGaD
Furosemide—CA14—Metabolism—CYP27B1—multiple sclerosis	4.01e-05	0.00427	CbGpPWpGaD
Furosemide—CA14—Metabolism—CYP24A1—multiple sclerosis	4.01e-05	0.00427	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3.98e-05	0.00424	CbGpPWpGaD
Furosemide—CA5A—Metabolism—CYP27B1—multiple sclerosis	3.91e-05	0.00417	CbGpPWpGaD
Furosemide—CA5A—Metabolism—CYP24A1—multiple sclerosis	3.91e-05	0.00417	CbGpPWpGaD
Furosemide—CA6—Metabolism—CYP24A1—multiple sclerosis	3.91e-05	0.00417	CbGpPWpGaD
Furosemide—CA6—Metabolism—CYP27B1—multiple sclerosis	3.91e-05	0.00417	CbGpPWpGaD
Furosemide—CA4—Metabolism—SRM—multiple sclerosis	3.83e-05	0.00408	CbGpPWpGaD
Furosemide—PGD—Metabolism—CYP27B1—multiple sclerosis	3.77e-05	0.00402	CbGpPWpGaD
Furosemide—PGD—Metabolism—CYP24A1—multiple sclerosis	3.77e-05	0.00402	CbGpPWpGaD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	3.75e-05	0.00399	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—IFNB1—multiple sclerosis	3.73e-05	0.00397	CbGpPWpGaD
Furosemide—CA14—Metabolism—GPC5—multiple sclerosis	3.67e-05	0.00391	CbGpPWpGaD
Furosemide—CA2—Metabolism—SRM—multiple sclerosis	3.67e-05	0.00391	CbGpPWpGaD
Furosemide—CA7—Metabolism—CYP27B1—multiple sclerosis	3.65e-05	0.00389	CbGpPWpGaD
Furosemide—CA7—Metabolism—CYP24A1—multiple sclerosis	3.65e-05	0.00389	CbGpPWpGaD
Furosemide—CA5B—Metabolism—CYP27B1—multiple sclerosis	3.65e-05	0.00389	CbGpPWpGaD
Furosemide—CA5B—Metabolism—CYP24A1—multiple sclerosis	3.65e-05	0.00389	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3.6e-05	0.00383	CbGpPWpGaD
Furosemide—CA5A—Metabolism—GPC5—multiple sclerosis	3.58e-05	0.00381	CbGpPWpGaD
Furosemide—CA6—Metabolism—GPC5—multiple sclerosis	3.58e-05	0.00381	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.58e-05	0.00381	CbGpPWpGaD
Furosemide—SLCO2A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.56e-05	0.00379	CbGpPWpGaD
Furosemide—CA1—Metabolism—SRM—multiple sclerosis	3.52e-05	0.00375	CbGpPWpGaD
Furosemide—PGD—Metabolism—GPC5—multiple sclerosis	3.45e-05	0.00368	CbGpPWpGaD
Furosemide—CA12—Metabolism—CYP27B1—multiple sclerosis	3.38e-05	0.0036	CbGpPWpGaD
Furosemide—CA12—Metabolism—CYP24A1—multiple sclerosis	3.38e-05	0.0036	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—CCL5—multiple sclerosis	3.36e-05	0.00358	CbGpPWpGaD
Furosemide—CA1—C-MYB transcription factor network—MYC—multiple sclerosis	3.35e-05	0.00356	CbGpPWpGaD
Furosemide—CA7—Metabolism—GPC5—multiple sclerosis	3.34e-05	0.00356	CbGpPWpGaD
Furosemide—CA5B—Metabolism—GPC5—multiple sclerosis	3.34e-05	0.00356	CbGpPWpGaD
Furosemide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—multiple sclerosis	3.28e-05	0.00349	CbGpPWpGaD
Furosemide—PGD—NRF2 pathway—TGFB1—multiple sclerosis	3.26e-05	0.00348	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	3.13e-05	0.00333	CbGpPWpGaD
Furosemide—CA9—Metabolism—SRM—multiple sclerosis	3.09e-05	0.0033	CbGpPWpGaD
Furosemide—CA12—Metabolism—GPC5—multiple sclerosis	3.09e-05	0.0033	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	3.07e-05	0.00327	CbGpPWpGaD
Furosemide—CA14—Metabolism—RRM1—multiple sclerosis	3.04e-05	0.00324	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.02e-05	0.00321	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3e-05	0.0032	CbGpPWpGaD
Furosemide—SLC12A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.97e-05	0.00316	CbGpPWpGaD
Furosemide—CA5A—Metabolism—RRM1—multiple sclerosis	2.97e-05	0.00316	CbGpPWpGaD
Furosemide—CA6—Metabolism—RRM1—multiple sclerosis	2.97e-05	0.00316	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.91e-05	0.0031	CbGpPWpGaD
Furosemide—PGD—Metabolism—RRM1—multiple sclerosis	2.86e-05	0.00305	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.83e-05	0.00301	CbGpPWpGaD
Furosemide—ALB—Lipid and lipoprotein metabolism—APOE—multiple sclerosis	2.8e-05	0.00298	CbGpPWpGaD
Furosemide—CA7—Metabolism—RRM1—multiple sclerosis	2.77e-05	0.00295	CbGpPWpGaD
Furosemide—CA5B—Metabolism—RRM1—multiple sclerosis	2.77e-05	0.00295	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—APOE—multiple sclerosis	2.75e-05	0.00293	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.73e-05	0.0029	CbGpPWpGaD
Furosemide—CA4—Metabolism—CYP27B1—multiple sclerosis	2.7e-05	0.00287	CbGpPWpGaD
Furosemide—CA4—Metabolism—CYP24A1—multiple sclerosis	2.7e-05	0.00287	CbGpPWpGaD
Furosemide—PGD—Disease—RPL5—multiple sclerosis	2.68e-05	0.00285	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	2.65e-05	0.00282	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—IL4—multiple sclerosis	2.65e-05	0.00282	CbGpPWpGaD
Furosemide—CA2—Metabolism—CYP27B1—multiple sclerosis	2.59e-05	0.00275	CbGpPWpGaD
Furosemide—CA2—Metabolism—CYP24A1—multiple sclerosis	2.59e-05	0.00275	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	2.59e-05	0.00275	CbGpPWpGaD
Furosemide—PGD—Disease—SLC11A1—multiple sclerosis	2.57e-05	0.00273	CbGpPWpGaD
Furosemide—CA12—Metabolism—RRM1—multiple sclerosis	2.56e-05	0.00273	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.5e-05	0.00266	CbGpPWpGaD
Furosemide—CA1—Metabolism—CYP24A1—multiple sclerosis	2.48e-05	0.00264	CbGpPWpGaD
Furosemide—CA1—Metabolism—CYP27B1—multiple sclerosis	2.48e-05	0.00264	CbGpPWpGaD
Furosemide—CA4—Metabolism—GPC5—multiple sclerosis	2.47e-05	0.00263	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.38e-05	0.00254	CbGpPWpGaD
Furosemide—CA2—Metabolism—GPC5—multiple sclerosis	2.37e-05	0.00252	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	2.33e-05	0.00248	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—CCL2—multiple sclerosis	2.31e-05	0.00246	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.28e-05	0.00242	CbGpPWpGaD
Furosemide—CA1—Metabolism—GPC5—multiple sclerosis	2.27e-05	0.00242	CbGpPWpGaD
Furosemide—ALB—Hemostasis—CD58—multiple sclerosis	2.21e-05	0.00236	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SELPLG—multiple sclerosis	2.21e-05	0.00236	CbGpPWpGaD
Furosemide—ALB—Hemostasis—MERTK—multiple sclerosis	2.21e-05	0.00236	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.21e-05	0.00235	CbGpPWpGaD
Furosemide—CA9—Metabolism—CYP27B1—multiple sclerosis	2.18e-05	0.00232	CbGpPWpGaD
Furosemide—CA9—Metabolism—CYP24A1—multiple sclerosis	2.18e-05	0.00232	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.16e-05	0.0023	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.11e-05	0.00224	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—ICAM1—multiple sclerosis	2.1e-05	0.00224	CbGpPWpGaD
Furosemide—PGD—Disease—CD28—multiple sclerosis	2.05e-05	0.00218	CbGpPWpGaD
Furosemide—CA4—Metabolism—RRM1—multiple sclerosis	2.05e-05	0.00218	CbGpPWpGaD
Furosemide—CA9—Metabolism—GPC5—multiple sclerosis	1.99e-05	0.00212	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—IFNG—multiple sclerosis	1.97e-05	0.0021	CbGpPWpGaD
Furosemide—CA2—Metabolism—RRM1—multiple sclerosis	1.96e-05	0.00209	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.91e-05	0.00203	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—CCL2—multiple sclerosis	1.88e-05	0.00201	CbGpPWpGaD
Furosemide—CA1—Metabolism—RRM1—multiple sclerosis	1.88e-05	0.002	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.81e-05	0.00192	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.8e-05	0.00192	CbGpPWpGaD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.77e-05	0.00189	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	1.76e-05	0.00187	CbGpPWpGaD
Furosemide—CA14—Metabolism—BCHE—multiple sclerosis	1.75e-05	0.00186	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.74e-05	0.00186	CbGpPWpGaD
Furosemide—CA5A—Metabolism—BCHE—multiple sclerosis	1.7e-05	0.00181	CbGpPWpGaD
Furosemide—CA6—Metabolism—BCHE—multiple sclerosis	1.7e-05	0.00181	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	1.67e-05	0.00178	CbGpPWpGaD
Furosemide—CA9—Metabolism—RRM1—multiple sclerosis	1.65e-05	0.00176	CbGpPWpGaD
Furosemide—PGD—Metabolism—BCHE—multiple sclerosis	1.64e-05	0.00175	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	1.63e-05	0.00173	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—IFNG—multiple sclerosis	1.6e-05	0.0017	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.59e-05	0.00169	CbGpPWpGaD
Furosemide—CA7—Metabolism—BCHE—multiple sclerosis	1.59e-05	0.00169	CbGpPWpGaD
Furosemide—CA5B—Metabolism—BCHE—multiple sclerosis	1.59e-05	0.00169	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.56e-05	0.00166	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.54e-05	0.00164	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.53e-05	0.00163	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.53e-05	0.00163	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.51e-05	0.00161	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	1.5e-05	0.00159	CbGpPWpGaD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.49e-05	0.00159	CbGpPWpGaD
Furosemide—CA12—Metabolism—BCHE—multiple sclerosis	1.47e-05	0.00157	CbGpPWpGaD
Furosemide—PGD—Disease—CD86—multiple sclerosis	1.46e-05	0.00156	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—IL1B—multiple sclerosis	1.43e-05	0.00152	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—IL2—multiple sclerosis	1.42e-05	0.00151	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PLEK—multiple sclerosis	1.37e-05	0.00146	CbGpPWpGaD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.35e-05	0.00144	CbGpPWpGaD
Furosemide—PGD—Disease—CCR5—multiple sclerosis	1.3e-05	0.00138	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	1.27e-05	0.00136	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	1.27e-05	0.00135	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—STAT3—multiple sclerosis	1.27e-05	0.00135	CbGpPWpGaD
Furosemide—PGD—Disease—HLA-A—multiple sclerosis	1.26e-05	0.00135	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.18e-05	0.00126	CbGpPWpGaD
Furosemide—PGD—Disease—APOE—multiple sclerosis	1.18e-05	0.00126	CbGpPWpGaD
Furosemide—CA4—Metabolism—BCHE—multiple sclerosis	1.17e-05	0.00125	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—MAPK1—multiple sclerosis	1.15e-05	0.00123	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	1.13e-05	0.00121	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.13e-05	0.0012	CbGpPWpGaD
Furosemide—CA2—Metabolism—BCHE—multiple sclerosis	1.13e-05	0.0012	CbGpPWpGaD
Furosemide—ABCC2—NRF2 pathway—TGFB1—multiple sclerosis	1.1e-05	0.00117	CbGpPWpGaD
Furosemide—CA1—Metabolism—BCHE—multiple sclerosis	1.08e-05	0.00115	CbGpPWpGaD
Furosemide—PGD—Disease—CD80—multiple sclerosis	1.07e-05	0.00114	CbGpPWpGaD
Furosemide—CA14—Metabolism—APOE—multiple sclerosis	1.05e-05	0.00112	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—TNF—multiple sclerosis	1.04e-05	0.0011	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	1.03e-05	0.00109	CbGpPWpGaD
Furosemide—CA5A—Metabolism—APOE—multiple sclerosis	1.02e-05	0.00109	CbGpPWpGaD
Furosemide—CA6—Metabolism—APOE—multiple sclerosis	1.02e-05	0.00109	CbGpPWpGaD
Furosemide—PGD—Metabolism—APOE—multiple sclerosis	9.88e-06	0.00105	CbGpPWpGaD
Furosemide—ALB—Metabolism—SRM—multiple sclerosis	9.65e-06	0.00103	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SELE—multiple sclerosis	9.63e-06	0.00103	CbGpPWpGaD
Furosemide—CA5B—Metabolism—APOE—multiple sclerosis	9.56e-06	0.00102	CbGpPWpGaD
Furosemide—CA7—Metabolism—APOE—multiple sclerosis	9.56e-06	0.00102	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—TGFB1—multiple sclerosis	9.52e-06	0.00101	CbGpPWpGaD
Furosemide—CA9—Metabolism—BCHE—multiple sclerosis	9.49e-06	0.00101	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	9.36e-06	0.000996	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	9.23e-06	0.000983	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	9.06e-06	0.000965	CbGpPWpGaD
Furosemide—CA14—Metabolism—POMC—multiple sclerosis	9.03e-06	0.000962	CbGpPWpGaD
Furosemide—PGD—Disease—TYK2—multiple sclerosis	9.01e-06	0.000959	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—ALB—multiple sclerosis	9e-06	0.000958	CbGpPWpGaD
Furosemide—CA12—Metabolism—APOE—multiple sclerosis	8.86e-06	0.000943	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—IL6—multiple sclerosis	8.85e-06	0.000942	CbGpPWpGaD
Furosemide—CA6—Metabolism—POMC—multiple sclerosis	8.8e-06	0.000937	CbGpPWpGaD
Furosemide—CA5A—Metabolism—POMC—multiple sclerosis	8.8e-06	0.000937	CbGpPWpGaD
Furosemide—PGD—Metabolism—POMC—multiple sclerosis	8.49e-06	0.000904	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—IL6—multiple sclerosis	8.36e-06	0.00089	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.27e-06	0.000881	CbGpPWpGaD
Furosemide—CA14—Metabolism—ALB—multiple sclerosis	8.23e-06	0.000877	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	8.23e-06	0.000877	CbGpPWpGaD
Furosemide—CA5B—Metabolism—POMC—multiple sclerosis	8.22e-06	0.000875	CbGpPWpGaD
Furosemide—CA7—Metabolism—POMC—multiple sclerosis	8.22e-06	0.000875	CbGpPWpGaD
Furosemide—PGD—Disease—CD4—multiple sclerosis	8.15e-06	0.000867	CbGpPWpGaD
Furosemide—CA5A—Metabolism—ALB—multiple sclerosis	8.02e-06	0.000854	CbGpPWpGaD
Furosemide—CA6—Metabolism—ALB—multiple sclerosis	8.02e-06	0.000854	CbGpPWpGaD
Furosemide—PGD—Metabolism—ALB—multiple sclerosis	7.74e-06	0.000824	CbGpPWpGaD
Furosemide—CA12—Metabolism—POMC—multiple sclerosis	7.61e-06	0.00081	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.59e-06	0.000808	CbGpPWpGaD
Furosemide—CA7—Metabolism—ALB—multiple sclerosis	7.49e-06	0.000798	CbGpPWpGaD
Furosemide—CA5B—Metabolism—ALB—multiple sclerosis	7.49e-06	0.000798	CbGpPWpGaD
Furosemide—CA4—Metabolism—APOE—multiple sclerosis	7.07e-06	0.000752	CbGpPWpGaD
Furosemide—ALB—Hemostasis—ITGA4—multiple sclerosis	6.96e-06	0.000742	CbGpPWpGaD
Furosemide—CA12—Metabolism—ALB—multiple sclerosis	6.94e-06	0.000739	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IFNB1—multiple sclerosis	6.91e-06	0.000736	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.86e-06	0.000731	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP27B1—multiple sclerosis	6.8e-06	0.000724	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP24A1—multiple sclerosis	6.8e-06	0.000724	CbGpPWpGaD
Furosemide—CA2—Metabolism—APOE—multiple sclerosis	6.77e-06	0.000721	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.65e-06	0.000708	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	6.64e-06	0.000707	CbGpPWpGaD
Furosemide—CA1—Metabolism—APOE—multiple sclerosis	6.49e-06	0.000692	CbGpPWpGaD
Furosemide—PGD—Disease—STAT3—multiple sclerosis	6.31e-06	0.000672	CbGpPWpGaD
Furosemide—ALB—Metabolism—GPC5—multiple sclerosis	6.22e-06	0.000662	CbGpPWpGaD
Furosemide—CA4—Metabolism—POMC—multiple sclerosis	6.07e-06	0.000646	CbGpPWpGaD
Furosemide—PGD—Disease—MYC—multiple sclerosis	5.86e-06	0.000624	CbGpPWpGaD
Furosemide—PGD—Disease—TGFB1—multiple sclerosis	5.85e-06	0.000623	CbGpPWpGaD
Furosemide—CA2—Metabolism—POMC—multiple sclerosis	5.82e-06	0.00062	CbGpPWpGaD
Furosemide—PGD—Disease—MAPK1—multiple sclerosis	5.73e-06	0.00061	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.73e-06	0.00061	CbGpPWpGaD
Furosemide—CA9—Metabolism—APOE—multiple sclerosis	5.71e-06	0.000608	CbGpPWpGaD
Furosemide—CA1—Metabolism—POMC—multiple sclerosis	5.58e-06	0.000594	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.55e-06	0.000591	CbGpPWpGaD
Furosemide—CA4—Metabolism—ALB—multiple sclerosis	5.53e-06	0.000589	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	5.41e-06	0.000576	CbGpPWpGaD
Furosemide—CA2—Metabolism—ALB—multiple sclerosis	5.31e-06	0.000565	CbGpPWpGaD
Furosemide—ALB—Metabolism—RRM1—multiple sclerosis	5.15e-06	0.000549	CbGpPWpGaD
Furosemide—CA1—Metabolism—ALB—multiple sclerosis	5.09e-06	0.000542	CbGpPWpGaD
Furosemide—CA9—Metabolism—POMC—multiple sclerosis	4.91e-06	0.000522	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IL2RA—multiple sclerosis	4.76e-06	0.000507	CbGpPWpGaD
Furosemide—CA9—Metabolism—ALB—multiple sclerosis	4.47e-06	0.000476	CbGpPWpGaD
Furosemide—PGD—Disease—IL6—multiple sclerosis	4.41e-06	0.000469	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	4.22e-06	0.000449	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	4.14e-06	0.000441	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4e-06	0.000426	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.43e-06	0.000366	CbGpPWpGaD
Furosemide—ALB—Metabolism—BCHE—multiple sclerosis	2.96e-06	0.000315	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IL2—multiple sclerosis	2.79e-06	0.000297	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TGFB1—multiple sclerosis	2.18e-06	0.000232	CbGpPWpGaD
Furosemide—ALB—Hemostasis—MAPK1—multiple sclerosis	2.13e-06	0.000227	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOE—multiple sclerosis	1.78e-06	0.00019	CbGpPWpGaD
Furosemide—ALB—Metabolism—POMC—multiple sclerosis	1.53e-06	0.000163	CbGpPWpGaD
